Cognitive Impairment Biomarkers Market

Future Market Insights

Key Insight

The cognitive impairment biomarkers market is projected to grow from USD 8.8 billion in 2025 to USD 14.3 billion by 2035, at a CAGR of 5.0%. Genomics Biomarker will dominate with a 27.4% market share, while alzheimer’s diseases will lead the application segment with a 34.6% share.

September 26, 2025

Anurag Sharma

250 Pages

Cite this Report

Cognitive Impairment Biomarkers Market

https://www.futuremarketinsights.com/reports/cognitive-impairment-biomarkers-market

License

Buy Now

Summary ToC Companies

Key Players

ADx NeuroSciences NV
Banyan Biomarkers Inc
Bio-Rad Laboratories

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Cognitive Impairment Biomarkers Market

Key Players

Similar Industry Reports